Literature DB >> 20497667

In-hospital delay to primary angioplasty for patients with ST-elevated myocardial infarction between cardiac specialized hospitals and non-specialized hospitals in Beijing, China.

Yi-Wen Xun1, Jin-Gang Yang, Li Song, Yi-Hong Sun, Chang-Lin Lu, Yue-Jin Yang, Da-Yi Hu.   

Abstract

BACKGROUND: Evidence indicates that early reperfusion therapy in patients with ST-elevation myocardial infarction (STEMI) reduces complications. This study was undertaken to compare the in-hospital delay to primary percutaneous coronary intervention (PPCI) for patients with STEMI between specialized hospitals and non-specialized hospitals in Beijing, China.
METHODS: Two specialized hospitals and fifteen non-specialized hospitals capable of performing PPCI were selected to participate in this study. A total of 308 patients, within 12 hours of the onset of symptoms and undergoing PPCI between November 1, 2005 and December 31, 2006 were enrolled. Data were collected by structured interview and review of medical records.
RESULTS: The median in-hospital delay was 98 (interquartile range 105 to 180) minutes, and 16.9% of the patients were treated within 90 minutes. Total in-hospital delay and ECG-to-treatment decision-making time were longer in the non-specialized hospitals than in the cardiac specialized hospitals (147 minutes vs. 120 minutes, P < 0.001; 55 minutes vs. 45 minutes, P = 0.035). After controlling the confounding factors, the non-specialized hospitals were independently associated with an increased risk of being in the upper median of in-hospital delays.
CONCLUSIONS: There were substantial in-hospital delays between arrival at the hospital and the administration of PPCI for patients with STEMI in Beijing. Patients admitted to the cardiac specialized hospitals had a shorter in-hospital delay than those to the non-specialized hospitals because of a shorter time of ECG-to-treatment decision-making.

Entities:  

Mesh:

Year:  2010        PMID: 20497667

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Identifying patients with refusal of percutaneous coronary intervention for acute myocardial infarction: a classification and regression tree analysis.

Authors:  Manyan Wu; Long Li; Sufang Li; Yuxia Cui; Dan Hu; Junxian Song; Chongyou Lee; Hong Chen
Journal:  Intern Emerg Med       Date:  2019-04-04       Impact factor: 3.397

2.  An artificial intelligence-based risk prediction model of myocardial infarction.

Authors:  Ran Liu; Miye Wang; Tao Zheng; Rui Zhang; Nan Li; Zhongxiu Chen; Hongmei Yan; Qingke Shi
Journal:  BMC Bioinformatics       Date:  2022-06-07       Impact factor: 3.307

3.  Rationale and design of the OPTIMAL-REPERFUSION trial: A prospective randomized multi-center clinical trial comparing different fibrinolysis-transfer percutaneous coronary intervention strategies in acute ST-segment elevation myocardial infarction.

Authors:  Zhongxiu Chen; Duolao Wang; Min Ma; Chen Li; Zhi Wan; Li Zhang; Ye Zhu; Mian Wang; Hua Wang; Sen He; Yong Peng; Jiafu Wei; Baotao Huang; Yong He
Journal:  Clin Cardiol       Date:  2021-02-25       Impact factor: 2.882

4.  STEMI Outcomes in Guangzhou and Hong Kong: Two-Centre Retrospective Interregional Study.

Authors:  Xiaohui Chen; Min Li; Huilin Jiang; Yunmei Li; Junrong Mo; Peiyi Lin; Colin A Graham; Timothy H Rainer
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.